Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin Pre-treatment in Recurrent Hepatitis C
NCT00993122Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Oct 2009
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ribavirin in hepatitis C virus infection, sponsored by Sapienza University of Rome. Started Oct 2009; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00993122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993122.